# Study of Inactivated SARS-CoV-2 Vaccine (Vero Cells) in Healthy Population Aged 3 to 17 Years(COVID-19)

> **NCT05003466** · PHASE2 · UNKNOWN · sponsor: **Shenzhen Kangtai Biological Products Co., LTD** · enrollment: 480 (estimated)

## Conditions studied

- COVID-19

## Interventions

- **BIOLOGICAL:** SARS-CoV-2 Vaccine (Vero Cells), Inactivated
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT05003466
- **Lead sponsor:** Shenzhen Kangtai Biological Products Co., LTD
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-09
- **Primary completion:** 2023-03
- **Final completion:** 2023-04
- **Target enrollment:** 480 (ESTIMATED)
- **Last updated:** 2021-08-18

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05003466

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05003466, "Study of Inactivated SARS-CoV-2 Vaccine (Vero Cells) in Healthy Population Aged 3 to 17 Years(COVID-19)". Retrieved via MORVS 2026-10-16 from https://api.morvs.ai/clinical/NCT05003466. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*